ArticleLife (Basel, Switzerland)2022

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Elke Boxhammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.